Epstein-Barr virus (EBV) reactivation and cellmediated immune (CMI) responses were followed in 16 Antarctic expeditioners during winter-over isolation at 2 Australian National Antarctic Research Expedition stations. Delayedtype hypersensitivity (DTH) skin testing was used as an indicator of the CMI
Cell mediated immunity during infectious mono-nucleosis to epstein-barr virus associated antigens
✍ Scribed by Phillip Periman; P. H. Levine; D. V. Ablashi; Ivor Royston
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 535 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Twenty‐three patients with recent infectious mononucleosis were studied for cell‐mediated immunity to Epstein‐Barr virus (EBV)‐associated antigens. By means of a virion‐containing antigen preparation, (P3J), leukocyte migration inhibition was demonstrated in 6 of 13 patients with acute infectious mononucleosis (IM) and in 6 of 10 patients studied during the convalescent period. Inhibition with a soluble antigen (S) preparation was seen in only a few patients at all stages of the illness. Lymphocyte blast transformation on exposure to P3J occurred in 4 of 9 patients with acute IM; no other study group reacted. Control donors lacking anti‐EBV antibodies did not demonstrate migration inhibition or blast transformation with either P3J or S. Control donors with evidence of previous EBV infection did demonstrate migration inhibition with P3J (8 of 12) and S (3 of 10). These studies indicated that cell‐mediated immunity to EBV‐associated antigens could be detected by either leukocyte migration inhibition or lymphocyte blast transformation, but neither assay is diagnostic of infectious mononucleosis.
📜 SIMILAR VOLUMES
## Abstract Under appropriate culture conditions, EB virus infection of lymphocytes from seropositive donors leads to regression of transformation, and this was shown previously to be due to activation in a secondary immune response of T lymphocytes inhibitory for the autologous lymphoblastoid cell
## Abstract Differential induction of Epstein‐Barr virus (EBV)‐related antigens was observed after Sendai virusmediated fusion of producer and non‐producer cells with various human and mouse cells. The EBV‐determined early nuclear antigen (ENA), early antigen (EA) and viral capsid antigen (VCA) cou
## Abstract Peripheral blood lymphocytes from normal seropositive donors and renal transplant recipients on various immunosuppressive regimens have been tested for their ability to mount a cytotoxic response when cultured with autologous EB virus‐infected B cells and thereby to cause regression of
## Abstract The activity of T‐cell‐mediated immunity to Epstein‐Barr virus (EBV) was assessed by an assay of regression of the outgrowth of EBV‐infected autologous B cells. Regression and natural killer (NK)‐cell activities were compared for patients and their mothers from five families with X‐link